BD Launches New Safety Pen Needle

BD (Becton, Dickinson and Company), a leading global medical technology company, have announced the launch of the 5mm BD AutoShield™ Safety Pen Needle. The safety-engineered design of the pen needles enables healthcare workers and carers deliver safe, comfortable injections to people with diabetes.

It is estimated that one million needlestick injuries occur in the European Union each year , with more than 100,000 needlestick injuries occurring each year in the UK alone. They are particularly dangerous in view of the potential for transmitting life-threatening blood-borne pathogens, such as hepatitis B (HBV), hepatitis C (HCV) and HIV.

“Needlestick injuries are the most frequent occupational hazard faced by healthcare workers, including those caring for people with diabetes” said Carol Philipps, Business Director, UK and Ireland, BD Medical - Diabetes Care. “Helping people with diabetes and their carers manage their condition as safely and effectively as possible is very important to us. The BD AutoShield™ Safety Pen Needle is the latest in our portfolio of innovative products designed to help protect healthcare workers and patients from needlestick injury and possible infection.”

The BD AutoShield™ Safety Pen Needle incorporates a shield that automatically locks after injection to help prevent accidental needlestick injuries. Available in 29Gx5mm needle size in the UK, they are the only safety-engineered pen needles compatible with all brands of pens for diabetes treatment. Shorter needles are proven to be as effective as longer needles for patients of all body types, as well as offering a less intimidating and less painful injection experience , while reducing the risk of intramuscular injections.

For more information please click on the 'company article page' link